communityacquir
pneumonia
cap
lead
infecti
caus
death
worldwid
respiratori
virus
whose
pathogen
role
underestim
mani
year
account
adult
cap
case
human
adenovirus
hadv
nonenvelop
doublestrand
dna
virus
ubiquit
environ
also
common
caus
respiratori
infect
hadv
pneumonia
typic
limit
newborn
immunocompromis
host
school
militari
camp
popul
sever
hadv
pneumonia
frequent
describ
immunocompromis
patient
respiratori
infect
caus
hadv
immunocompet
patient
usual
thought
mild
selflimit
howev
advanc
modern
molecular
techniqu
hadv
increasingli
found
involv
sporad
case
outbreak
sever
cap
healthi
adult
date
least
hadv
genotyp
recogn
assign
seven
subgroup
accord
genet
biophys
biochem
characterist
speci
b
predomin
hadv
speci
associ
respiratori
infect
among
adult
genotyp
recombin
report
caus
sporad
outbreak
event
cap
turkey
singapor
korea
china
sequenti
outbreak
sever
provinc
region
china
gain
increas
attent
sinc
one
pathogen
cap
hadv
account
adult
cap
case
northern
china
account
identifi
hadv
posit
sampl
compar
studi
show
serotyp
hadv
may
one
factor
determin
sever
adenovir
pneumonia
thought
close
associ
sever
pneumonia
compar
serotyp
clinic
understand
sever
cap
induc
still
limit
though
pathogen
fulli
character
wholegenom
sequenc
current
knowledg
sever
pneumonia
mainli
deriv
singl
case
report
rel
small
singlecent
seri
begin
februari
viru
screen
carri
etiolog
studi
adult
sever
cap
peke
union
medic
colleg
hospit
pumch
beij
second
hospit
hebei
medic
univers
shhmu
hebei
provinc
china
two
institut
high
referr
rate
northern
china
encount
multipl
case
hadv
pneumonia
annual
present
multicent
case
seri
report
describ
detail
clinic
featur
outcom
sever
hadv
cap
immunocompet
adult
institut
ethic
review
board
pumch
shhmu
approv
retrospect
studi
data
studi
patient
analyz
anonym
requir
inform
consent
individu
patient
waiv
given
retrospect
natur
studi
perform
multicentr
retrospect
review
consecut
patient
diagnos
sever
hadv
cap
emerg
depart
intens
care
unit
icu
two
hospit
februari
april
criteria
sever
cap
defin
modifi
american
thorac
societi
criteria
risk
class
v
pneumonia
sever
index
psi
hadv
infect
confirm
posit
multiplex
polymeras
chain
reaction
pcr
hadv
lower
respiratori
tract
sampl
sputum
tracheal
aspir
bronchoalveolar
lavag
bal
fluid
addit
requir
neg
microbiolog
test
includ
bacteri
fungal
common
respiratori
virus
admiss
patient
hiv
infect
neutropenia
receiv
immunosuppress
chemotherapi
pregnant
breastfeed
women
malign
neoplasm
exclud
cap
patient
whose
clinic
condit
deterior
rapidli
despit
appropri
use
broadspectrum
antibiot
day
suspect
atyp
pneumonia
lower
respiratori
tract
sampl
urin
blood
acut
convalesc
serum
sampl
collect
thorough
microbiolog
test
includ
sputum
specimen
stain
microbiolog
cultur
urin
specimen
legionella
pneumophila
pneumonia
antigen
detect
blood
cultur
lower
respiratori
tract
sampl
viru
realtim
pcr
detect
test
virus
includ
hadv
rhinoviru
cytomegaloviru
influenza
viru
metapneumoviru
parainfluenza
viru
coronaviru
respiratori
syncyti
viru
acut
convalesc
serum
sampl
chlamydia
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
antibodi
titer
determin
lower
respiratori
tract
specimen
patient
sent
institut
medic
biolog
chines
academi
medic
scienc
test
respiratori
virus
viral
nucleic
acid
extract
specimen
use
nuclisen
easymag
system
marci
l
etoil
franc
multiplex
realtim
pcr
perform
screen
hadv
rhinoviru
cytomegaloviru
influenza
viru
metapneumoviru
parainfluenza
viru
coronaviru
respiratori
syncyti
viru
use
seeplex
rv
ace
detect
kit
seegen
inc
seoul
korea
accord
manufactur
instruct
specimen
posit
hadv
subject
analysi
determin
type
hadv
hadv
posit
specimen
subject
multiplex
pcr
assay
speci
speciesspecif
primer
pcr
target
hexon
gene
perform
typespecif
primer
pcr
product
purifi
qiagen
valencia
ca
usa
sequenc
use
genet
analyz
appli
biosystem
foster
citi
ca
usa
type
hadv
confirm
nucleotid
blast
analysi
use
blastn
program
nation
center
biotechnolog
inform
bethesda
md
usa
investig
creat
standard
data
form
clinic
inform
collect
includ
demograph
age
sex
smoke
statu
psi
score
assess
sever
ill
admiss
comorbid
clinic
symptom
eg
fever
chill
cough
sputum
dyspnea
chest
pain
diarrhea
myalgia
sore
throat
vital
sign
laboratori
test
arteri
blood
ga
analysi
result
microbiolog
find
includ
hadv
type
chest
radiolog
characterist
concomit
medic
respiratori
support
complic
eg
use
mechan
ventil
septic
shock
overal
outcom
also
record
continu
variabl
express
median
interquartil
rang
categor
variabl
number
percent
differ
group
assess
fisher
exact
test
categor
variabl
mannwhitney
u
test
continu
variabl
signific
fix
p
patient
sever
hadv
cap
usual
young
middleag
adult
median
age
year
rang
year
male
gender
common
femal
gender
patient
surviv
male
patient
nonimmunocompromis
three
patient
age
underli
diseas
hypertens
seven
patient
smoker
patient
patient
came
beijingtianjinhebei
region
northern
china
ill
patient
occur
winter
spring
season
hadv
identifi
april
definit
hadv
type
case
class
speci
b
type
two
type
one
type
one
type
see
fig
shown
tabl
flulik
symptom
fever
cough
littl
sputum
commonli
observ
onset
ill
patient
present
high
fever
median
bodi
temperatur
rang
persist
day
rang
day
clinic
symptom
sign
survivor
nonsurvivor
differ
except
psi
score
respiratori
rate
significantli
higher
nonsurvivor
p
respect
median
time
onset
icu
admiss
seven
day
patient
show
appar
dyspnea
admiss
arteri
blood
ga
analysi
icu
admiss
reveal
profound
hypoxia
median
mmhg
nonsurvivor
significantli
lower
survivor
p
differ
laboratori
find
survivor
nonsurvivor
except
hypersensit
crp
nonsurvivor
significantli
lower
survivor
p
tabl
white
blood
cell
count
patient
normal
rang
serum
aspart
aminotransferas
ast
lactat
dehydrogenas
ldh
creatinin
phosphokinas
ck
creatinin
urea
nitrogen
level
higher
nonsurvivor
differ
signific
consolid
groundgrass
opac
ggo
pleural
effus
common
find
sever
hadv
cap
tabl
diffus
ggo
reveal
predomin
two
patient
fig
within
one
week
ill
onset
focal
consolid
predomin
find
ten
patient
fig
three
patient
show
bilater
multipl
consolid
accompani
ggo
two
patient
fig
commonli
involv
lobe
right
lower
lobe
n
follow
left
lower
lobe
n
left
upper
lobe
n
right
upper
lobe
n
followup
radiolog
find
patient
consolid
show
rapid
develop
bilater
consolid
within
day
ill
onset
usual
accompani
adjac
ggo
pleural
effus
fig
fig
number
lobe
consolid
significantli
increas
nonsurvivor
survivor
p
parenchym
abnorm
began
absorb
two
week
ill
onset
appear
fibrosi
overal
treatment
outcom
studi
patient
summar
tabl
empir
broadspectrum
intraven
antibiot
given
patient
eight
prescrib
antivir
drug
antivir
treatment
start
prior
confirm
viral
pneumonia
studi
acylovir
gancyclovir
oseltamivir
ribavirin
wide
use
empir
china
studi
oseltamivir
use
eight
patient
receiv
antivir
drug
ribavirin
gancyclovir
use
combin
oseltamivir
four
three
patient
respect
ten
patient
receiv
adjuv
intraven
immunoglobulin
day
fourteen
receiv
corticosteroid
day
includ
hydrocortison
methylprednisolon
hospit
acquir
pulmonari
infect
develop
seven
case
acinetobact
baumannii
domin
pathogen
four
patient
surviv
one
case
die
respiratori
failur
caus
ard
three
patient
die
multipl
organ
dysfunct
syndrom
mainli
includ
respiratori
failur
septic
shock
need
mechan
ventil
andor
vasopressor
similar
nonsurvivor
survivor
length
icu
stay
durat
mechan
ventil
nonsurvivor
less
survivor
differ
signific
past
decad
adult
cap
induc
hadv
caus
increas
concern
worldwid
especi
china
hadv
account
adult
acut
respiratori
tract
infect
beij
frequent
detect
serotyp
howev
proport
hadv
cap
increas
follow
two
year
becam
predomin
culprit
thought
close
associ
sever
cap
result
studi
verifi
phenomenon
best
knowledg
number
patient
need
mechan
ventil
patient
report
significantli
two
six
case
recent
investig
relat
sever
cap
studi
may
provid
new
understand
clinic
characterist
relat
sever
cap
immunocompet
adult
demograph
report
consist
previou
investig
young
middleag
male
adult
suscept
host
sever
hadv
cap
patient
sever
hadv
cap
occur
winter
spring
season
influenza
epidem
indic
relationship
hadv
cap
influenza
may
appropri
focu
futur
research
sever
cap
caus
immunocompet
adult
china
previou
investig
occur
northern
china
mainli
baod
hebei
provinc
beij
wider
dispers
case
suggest
still
activ
northern
china
might
expand
scope
influenc
clinic
featur
diseas
progress
case
highli
similar
ard
caus
type
hadv
describ
previou
report
patient
present
high
fever
cough
common
manifest
hadv
infect
diarrhea
conjunct
common
patient
psi
score
one
commonli
use
sever
assess
tool
cap
also
provid
import
prognost
inform
induc
cap
report
absenc
underli
diseas
abnorm
laboratori
find
decreas
hematocrit
hyponatremia
hyperglycemia
highlight
contribut
abnorm
respiratori
rate
high
valu
saw
patient
psi
score
respiratori
rate
independ
risk
marker
inhospit
mortal
cap
low
crp
valu
commonli
consid
associ
less
sever
system
inflammatori
respons
reflect
better
prognosi
interestingli
data
show
among
patient
ard
caus
hadv
low
initi
serum
crp
level
admiss
correl
fatal
outcom
interpret
result
may
difficult
though
similar
phenomenon
found
sever
cap
caus
streptococcu
pneumonia
cap
patient
liver
cirrhosi
crp
acut
phase
protein
synthes
liver
respons
tissu
damag
may
reason
specul
sever
hadv
cap
accompani
slightli
elev
crp
may
indic
impair
protect
inflammatori
respons
accord
reput
respiratori
virus
caus
diffus
interstiti
infiltr
clark
report
bilater
ggo
common
abnorm
immunocompet
adult
adenoviru
pneumonia
howev
research
support
consolid
rather
interstiti
infiltr
main
imag
characterist
adenoviru
pneumonia
immunocompet
adult
date
adenoviru
viru
known
caus
focal
lobar
consolid
typic
manifest
bacteri
pneumonia
main
imag
abnorm
initi
imag
find
adenoviru
pneumonia
resembl
bacteri
pneumonia
may
mislead
diagnosi
treatment
gu
conclud
singl
lobar
segment
consolid
common
patient
without
ard
patient
ard
bilater
multilobar
lung
consolid
compar
survivor
report
nonsurvivor
extens
consolid
correl
respiratori
rate
present
specif
treatment
sever
hadv
pneumonia
high
mortal
rate
often
report
case
sever
hadv
pneumonia
among
patient
need
mechan
ventil
previou
report
sever
pneumonia
nine
case
die
earli
administr
cidofovir
show
possibl
effect
six
immunocompet
patient
random
control
trial
lack
cidofovir
avail
hospit
china
mortal
studi
rel
low
corticosteroid
frequent
use
studi
adjuv
corticosteroid
cap
ard
remain
controversi
improv
mortal
good
safeti
record
corticosteroid
given
patient
sever
cap
seen
metaanalys
howev
corticosteroid
also
found
independ
predictor
mortal
poor
outcom
multipl
studi
viral
pneumonia
effect
corticosteroid
sever
hadv
cap
still
uncertain
although
case
report
one
case
fatal
pneumonia
hypercytokinemia
puls
methylprednisolon
treatment
result
rapid
amelior
patient
respiratori
distress
studi
focus
sever
cap
caus
patient
receiv
corticosteroid
total
mortal
howev
given
small
sampl
size
design
noncontrol
studi
conclud
corticosteroid
help
sever
hadv
cap
studi
sever
limit
first
determin
hadv
type
especi
type
wholegenom
sequenc
perform
due
retrospect
natur
second
rel
small
number
case
rel
low
incid
sever
adenoviru
pneumonia
result
comparison
survivor
nonsurvivor
may
also
lead
bia
due
unequ
number
patient
group
final
treatment
effect
cidofovir
antivir
drug
could
compar
cidofovir
avail
two
hospit
studi
conclus
play
import
role
case
adenoviru
pneumonia
immunocompet
adult
northern
china
surveil
agent
caus
sever
cap
warrant
hadv
test
sever
cap
patient
initi
neg
bacteri
cultur
failur
respond
antibiot
even
though
imag
find
clinic
present
might
suggest
bacteri
pneumonia
